Astragalus polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCC

CONTEXT: Astragalus polysaccharide (APS) is a new tumour therapeutic drug, that has an inhibitory effect on a variety of solid tumours. Tumour cell immunosuppression is related to the up-regulation of programmed death ligand 1 (PD-L1). However, whether APS exerts its antitumor effect by regulating P...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lihua, Xu, Kecheng, Niu, Lizhi, Lin, Lizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467620/
https://www.ncbi.nlm.nih.gov/pubmed/36086826
http://dx.doi.org/10.1080/13880209.2022.2112963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467620/
https://www.ncbi.nlm.nih.gov/pubmed/36086826
http://dx.doi.org/10.1080/13880209.2022.2112963

Ejemplares similares